AEI Healthcare Portfolio VII
Legal trust name AEI Healthcare Portfolio VII DST
DST interests are illiquid private securities. You may lose some or all of your investment. Distributions, tax treatment, and exit timing are not guaranteed. Review the current Private Placement Memorandum before investing.
AEI Healthcare Portfolio VII DST is a Delaware statutory trust sponsored by AEI Capital that holds three purpose-built, single-tenant outpatient medical office buildings in Surprise, Arizona; Austin, Texas; and Bristol, Connecticut. The properties are net-leased to healthcare operators with terms running to 2037–2042 and a weighted-average remaining lease term of about 13.62 years. The trust is structured debt-free and all-cash, without mortgage financing. As of a July 9, 2026 issuer Form D/A filing, the offering listed $50.5 million in total amount, with roughly $36.7 million reported sold as of that date.

Debt-free, min $100K, Y1 5.00% to 6.14% Y10; WALT 13.6yr; leases to 2037-2042; ~50.85% still available 5/2026
Based on issuer-filed Form D notices through Jul 9, 2026. Amounts are self-reported, may lag current subscriptions, and do not confirm availability. A Form D filing does not mean the SEC approved, endorsed, or verified the offering.
Form D is an issuer notice filing. A filing does not mean the SEC approved, endorsed, or verified the offering.
Offering profile
Portfolio and tenants
The trust holds three purpose-built, single-tenant outpatient medical office buildings in Surprise (AZ), Austin (TX), and Bristol (CT), net-leased to healthcare operators with leases running to 2037–2042, annual rent escalators of 2.0%–2.5%, and a weighted-average remaining lease term of 13.62 years 1. Sponsor-sourced tenant disclosures identify HonorHealth in Surprise (lease to 2042), Texas Children's Hospital in Austin (lease to 2038), and a UnitedHealthcare tenant in Bristol (lease to 2037) 1.
Bristol acquisition
Independent reporting states that AEI Capital acquired a newly built medical office building at 1251 Farmington Avenue, Bristol, CT for $19.9 million (about $758 per square foot) from Endurance Properties on January 14, 2026, net-leased to UnitedHealthcare on a 12-year lease and acquired as a feeder asset for AEI's next DST offering 2.
Structure
Sponsor-sourced disclosures describe the offering as debt-free and all-cash, with no mortgage refinancing or interest-rate exposure at the trust level 1.
Concentration and structural considerations
Sponsor-sourced disclosures note the Bristol/UnitedHealthcare asset represents approximately 44% of in-place rent, a single-asset concentration; a thinly capitalized master tenant funded by a $500,000 affiliate demand promissory note with projected Year-1 net income of about $2,013; that the Bristol tenant is an operating subsidiary rather than the rated UnitedHealth Group parent, whose outlook was revised to negative by Fitch in July 2025; a Bristol rent escalator that caps at year 9; and reserves declining from $371,000 to about $67,764 by 2035 with a $221,000 Connecticut transfer-tax draw in Year 1 1.
Offering progress
An issuer-filed Form D/A dated July 9, 2026 reported a total offering amount of $50.5 million and $36,681,034 sold as of that filing date 3. Top1031's dated structured classification records roughly 73% sold, with a first filing on March 16, 2026 5. These are filing figures as of their dates and do not by themselves establish current availability.
Sponsor
AEI Capital Corporation, founded 1970 and headquartered in St. Paul, MN, reports approximately $1.61 billion in assets under management, a 153-program operating history, and 57 completed 1031 offerings averaging 6.37% annual cash-on-cash distributions (sponsor-reported) 4.
In the news
Frequently asked questions
Is AEI Healthcare Portfolio VII currently active?
AEI Healthcare Portfolio VII is classified by Top1031 as active. “Active” reflects the latest public record and does not confirm that interests remain available.
Where does Top1031 get the data for AEI Healthcare Portfolio VII?
Top1031 tracks this offering from SEC Form D filings and cited sponsor disclosures. Filing data may lag current subscriptions and does not mean the SEC approved or verified the offering.
